Kohjin Bio Co.,Ltd. Statistics
Want to see JP:177A full AI Analyst Report?
Kohjin Bio Co.,Ltd. (177A) Stock Statistics & Valuation Metrics
Total Valuation
Kohjin Bio Co.,Ltd. has a market cap or net worth of JPY 3.42B. The enterprise value is JPY 4.01B.
- Market Cap
- JPY 3.42B
- Enterprise Value
- JPY 4.01B
Share Statistics
Kohjin Bio Co.,Ltd. has 5,111,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,111,600
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Kohjin Bio Co.,Ltd.’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.13%.
- Return on Equity (ROE)
- 0.04
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 3.13%
- Return on Capital Employed (ROCE)
- 0.05
- Revenue Per Employee
- 28.06M
- Profits Per Employee
- 1.43M
- Employee Count
- 176
- Asset Turnover
- 0.55
- Inventory Turnover
- 3.53
Valuation Ratios
The current PE Ratio of Kohjin Bio Co.,Ltd. is 26.76. Kohjin Bio Co.,Ltd.’s PEG ratio is -0.33.
- PE Ratio
- 26.76
- PS Ratio
- 0.72
- PB Ratio
- 0.58
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.33
Income Statement
In the last 12 months, Kohjin Bio Co.,Ltd. had revenue of 4.94B and earned 251.02M in profits. Earnings per share was 49.11.
- Revenue
- 4.94B
- Gross Profit
- 1.86B
- Operating Income
- 341.54M
- Pretax Income
- 332.26M
- Net Income
- 251.02M
- EBITDA
- 766.46M
- Earnings Per Share (EPS)
- 49.11
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Kohjin Bio Co.,Ltd. pays an annual dividend of JPY 24.00, resulting in a dividend yield of 1.51%
- Dividend Per Share
- JPY 24.00
- Dividend Yield
- 1.51%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 3.74%
Stock Price Statistics
- Beta
- 0.38
- 52-Week Price Change
- -57.65%
- 50-Day Moving Average
- 796.12
- 200-Day Moving Average
- 1028.58
- Relative Strength Index (RSI)
- 23.84
- Average Volume (3m)
- 3,148
Important Dates
Kohjin Bio Co.,Ltd. upcoming earnings date is Feb 12, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 13, 2026
- Next Earnings Date
- Feb 12, 2027
- Ex-Dividend Date
- Mar 28, 2025
Financial Position
Kohjin Bio Co.,Ltd. as a current ratio of 1.80, with Debt / Equity ratio of 36.86%
- Current Ratio
- 1.80
- Quick Ratio
- 1.43
- Debt to Market Cap
- 0.30
- Net Debt to EBITDA
- -0.38
- Interest Coverage Ratio
- 8.98
Taxes
In the past 12 months, Kohjin Bio Co.,Ltd. has paid 81.24M in taxes.
- Income Tax
- 81.24M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Kohjin Bio Co.,Ltd. EV to EBITDA ratio is 4.83, with an EV/FCF ratio of 0.00.
- EV to Sales
- 0.61
- EV to EBITDA
- 4.83
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Kohjin Bio Co.,Ltd. has JPY 2.38B in cash and marketable securities with JPY 1.84B in debt, giving a net cash position of JPY 544.16M billion.
- Cash & Marketable Securities
- JPY 2.38B
- Total Debt
- JPY 1.84B
- Net Cash
- JPY 544.16M
- Net Cash Per Share
- JPY 106.46
- Tangible Book Value Per Share
- JPY 1,146.45
Margins
Gross margin is 35.65%, with operating margin of 3.32%, and net profit margin of 2.70%.
- Gross Margin
- 35.65%
- Operating Margin
- 3.32%
- Pretax Margin
- 3.83%
- Net Profit Margin
- 2.70%
- EBITDA Margin
- 12.57%
- EBIT Margin
- 4.04%
Analyst Forecast
The average price target for Kohjin Bio Co.,Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -9.46%
- EPS Growth Forecast
- -82.25%
Scores
- Smart Score
- ―
- AI Score
- 50

